Brown Advisory Inc. Increases Position in Global Medical REIT Inc. (NYSE:GMRE)

Brown Advisory Inc. increased its holdings in shares of Global Medical REIT Inc. (NYSE:GMRE - Free Report) by 21.3% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,616,524 shares of the company's stock after acquiring an additional 283,581 shares during the period. Brown Advisory Inc. owned approximately 2.42% of Global Medical REIT worth $14,145,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of GMRE. Geode Capital Management LLC boosted its holdings in Global Medical REIT by 1.6% in the 4th quarter. Geode Capital Management LLC now owns 1,647,979 shares of the company's stock worth $12,724,000 after buying an additional 25,820 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in Global Medical REIT by 10.3% in the 1st quarter. Bank of New York Mellon Corp now owns 1,550,157 shares of the company's stock worth $13,564,000 after purchasing an additional 144,671 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Global Medical REIT by 11.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 1,260,098 shares of the company's stock valued at $9,728,000 after buying an additional 128,449 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of Global Medical REIT by 2.8% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 877,096 shares of the company's stock valued at $6,771,000 after buying an additional 23,993 shares during the period. Finally, Pacific Ridge Capital Partners LLC raised its position in shares of Global Medical REIT by 31.9% during the 4th quarter. Pacific Ridge Capital Partners LLC now owns 712,101 shares of the company's stock valued at $5,497,000 after buying an additional 172,171 shares during the period. 57.52% of the stock is currently owned by institutional investors and hedge funds.

Global Medical REIT Stock Up 0.1%

Shares of NYSE:GMRE traded up $0.01 during trading on Monday, hitting $7.14. The company's stock had a trading volume of 942,554 shares, compared to its average volume of 514,677. The business has a 50 day moving average price of $6.67 and a two-hundred day moving average price of $7.56. The company has a market capitalization of $477.45 million, a PE ratio of 238.08, a P/E/G ratio of 1.22 and a beta of 1.16. The company has a debt-to-equity ratio of 1.44, a quick ratio of 0.26 and a current ratio of 0.26. Global Medical REIT Inc. has a fifty-two week low of $6.06 and a fifty-two week high of $10.46.

Global Medical REIT (NYSE:GMRE - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.22 EPS for the quarter, hitting analysts' consensus estimates of $0.22. Global Medical REIT had a net margin of 5.87% and a return on equity of 1.68%. The firm had revenue of $34.60 million during the quarter, compared to the consensus estimate of $35.49 million. As a group, research analysts expect that Global Medical REIT Inc. will post 0.81 EPS for the current fiscal year.

Global Medical REIT Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 9th. Shareholders of record on Friday, June 20th were paid a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 8.40%. Global Medical REIT's dividend payout ratio is presently 2,000.00%.

Insider Transactions at Global Medical REIT

In related news, CEO Mark Okey Decker, Jr. acquired 102,668 shares of the firm's stock in a transaction on Tuesday, June 24th. The stock was bought at an average price of $6.52 per share, for a total transaction of $669,395.36. Following the completion of the purchase, the chief executive officer directly owned 102,668 shares of the company's stock, valued at approximately $669,395.36. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 8.50% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Robert W. Baird cut their target price on Global Medical REIT from $10.00 to $9.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. Wall Street Zen lowered Global Medical REIT from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. Finally, B. Riley assumed coverage on shares of Global Medical REIT in a research note on Thursday, April 3rd. They issued a "neutral" rating and a $9.00 price target for the company. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $10.44.

About Global Medical REIT

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.